Although these results did not differentiate between alcoholic liver disease and NAFLD/NASH, they were furtherly confirmed in a cohort of 130 patients with HCC in which NAFLD was associated with shortened survival after PD-1 therapy [50]. Here, PDCD1 is linked to metabolic dysfunction-associated steatohepatitis.